PHYSICIANS ARE IGNORING DTC DRUG ADS, STUDY CONCLUDES

MARCH 01, 2007

The pharmaceutical industry's heavy spending on direct-to-consumer (DTC) drug advertising may not be paying off by increasing sales for the promoted products, reported researchers at the Medical University of South Carolina.

Although the study found that the television ads made patients more aware of medications such as Pfizer's Celebrex (celecoxib) and Merck's withdrawn drug Vioxx (rofecoxib), the researchers uncovered little evidence that physicians actually were prescribing more of the advertised drugs. The researchers called that finding good news, noting that it suggests that the effects of DTC advertising may not be as "pernicious" as many critics feared.




SHARE THIS SHARE THIS
0

Conference Coverage

Check back here regularly for live conference coverage from the American Academy of Pain Medicine and the upcoming American Pharmacists Association Meeting and Expo. 


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.